JERUSALEM (Reuters) – Israel’s Together has agreed to sell 5 tonnes of cannabis oil to an unnamed Canadian company that will potentially bring revenue of hundreds of millions of shekels.
FILE PHOTO: A worker collects cuttings from a marijuana plant at the Canopy Growth Corporation facility in Smiths Falls, Ontario, Canada, January 4, 2018. REUTERS/Chris Wattie//File Photo
The Canadian company will buy from Together subsidiary Globus Pharma 50 tonnes of dried inflorescences of cannabis each year, which is equivalent to five tonnes of medical cannabis oil.
The two companies will also collaborate in the field of research and development and promoting technologies in the medical cannabis sector. They have estimated sales will amount to $3.17 to $4.7 per gram of inflorescence.
Investors have piled into cannabis stocks, such as Canadian producers Aurora and Canopy Growth, as many countries consider legalizing marijuana at least for medicinal purposes, such as a treatment for chronic pain, post-traumatic stress disorder, side effects from cancer therapy and other ailments.
Canada approved medical pot in 2001 and will legalize recreational use by July.
The parties intend to draw up a detailed agreement as soon as possible, which will fix the price of the sale of the various cannabis products according to prices on the Canadian market at the time of signing, the company said in a statement.
Globus plans to provide the Canadian company with medical cannabis from farms in Israel subject to receiving an export permit for medical cannabis, or from its farm in an overseas country, which has an export agreement with Canada.
FILE PHOTO: Droplets of oil form on the surface of a Cannabis plant in a state-owned agricultural farm in Rovigo, about 60 km (40 miles) from Venice, September 22, 2014. REUTERS/Alessandro Bianchi/File Photo
The Canadian company is currently applying for a license to